University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Grand Rounds > Single Pill Combinations in HIV Treatment
Single Pill Combinations in HIV Treatment
greyline
November 13, 2013
transparent gif
transparent gif
Monica Gandhi
Back to CME Grand Rounds
Description
Presenter: Monica Gandhi, MD, MPH
Video ClipWatch the Presentation YouTube Icon View on YouTube
SlidesView Slides Without Audio
Description

Monica Gandhi discusses the advantages and disadvantages of using single pill combinations (SPCs) for antiretroviral therapy, reviews the evidence on whether use of SPCs improves adherence and discusses studies that support the use of various co-formulations. She goes on to describe anticipated SPCs and the impact of healthcare reform and generics on the use of SPCs.

Presenter: Monica Gandhi, MD, MPH

Monica Gandhi, MD, is an Associate Professor of Medicine, UCSF Division of HIV/AIDS. She specializes in the care of HIV-infected women. Her research has focused on HIV/AIDS in women from the Women's Interagency HIV Study (WIHS), a large, multisite prospective cohort established in 1994 to study the natural history and clinical and laboratory findings of HIV in women in the United States.